Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,505.20
(
-1.53%
)
US TECH 100
23,263.60
(
-1.93%
)
Dow Jones
45,537.15
(
-1.05%
)
Brent Oil
108.74
(
4.12%
)
Bitcoin
69,706.01
(
-0.28%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

GrthzGd

Send PM Follow Ignore
Followers 15
Posts 1612
Boards Moderated 1
Alias Born 09/07/2010

GrthzGd

Re: DewDiligence post# 173953

Monday, 02/10/2014 11:15:25 AM

Monday, February 10, 2014 11:15:25 AM

Post# of 257262
Agreed, Sandoz/Novartis seems to specialize in pre-approval drug manufacture, based not only on its lightening quick, Enoxaparin launch three summers ago, but also on its near pre-approval Gleevec launch, as dramatically described in The Magic Cancer Bullet (2004,) (recommended by Biomaven-thx).
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today